Efficacy and safety of FOLFIRI/aflibercept in second‐line treatment of metastatic colorectal cancer in a real‐world population: Prognostic and predictive markers

PURPOSE: The phase III VELOUR trial demonstrated efficacy with combined FOLFIRI‐aflibercept in patients with metastatic colorectal cancer previously treated with oxaliplatin with or without bevacizumab versus placebo. The effect of FOLFIRI‐aflibercept in routine clinical practice was evaluated. METH...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Med
Main Authors: Fernández Montes, Ana, Martínez Lago, Nieves, Covela Rúa, Marta, de la Cámara Gómez, Juan, González Villaroel, Paula, Méndez Méndez, José Carlos, Jorge Fernández, Mónica, Salgado Fernández, Mercedes, Reboredo López, Margarita, Quintero Aldana, Guillermo, Luz Pellón Augusto, María, Graña Suárez, Begoña, García Gómez, Jesús
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2019
Assuntos:
Clinical Cancer Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6434192/
https://ncbi.nlm.nih.gov/pubmed/30690930
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1903
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados